Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:liver measurement
go back to main search page
Accession:CMO:0001064 term browser browse the term
Definition:Any measurement, morphological or physiological, involving the liver or any part thereof. The liver is the large, dark-red organ located in the cranial portion of the abdomen of vertebrates, just behind or below the diaphragm, the functions of which include storage and filtration of blood; secretion of bile; detoxification of noxious substances; conversion of sugars into glycogen; synthesis and breakdown of fats and temporary storage of fatty acids; and synthesis of serum proteins.


show annotations for term's descendants           Sort by:
area of individual liver tumorous lesion term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar6 Hepatocarcinoma resistance QTL 6 IDA RGD PMID:10850431 RGD:619609
liver cholesterol level term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hpcl1 Hepatic cholesterol level QTL 1 IDA RGD PMID:9600105 RGD:629576 NCBI chr10:35,392,267...51,793,994 JBrowse link
Q Hpcl2 Hepatic cholesterol level QTL 2 IDA RGD PMID:18071061 RGD:1643359 NCBI chr10:45,029,650...95,600,334 JBrowse link
liver copper weight to liver dry weight ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcuc1 Hepatic copper content QTL 1 IDA RGD PMID:11741328 RGD:619607
Q Hcuc3 Hepatic copper content QTL 3 IDA RGD PMID:12094018 RGD:629572 NCBI chr 2:229,059,610...249,053,267 JBrowse link
Q Hcuc4 Hepatic copper content QTL 4 IDA RGD PMID:12094018 RGD:629572 NCBI chr10:66,941,813...73,452,992 JBrowse link
liver nonremodeling tumorous lesion number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar14 Hepatocarcinoma resistance QTL 14 IDA RGD PMID:15185337 RGD:737884 NCBI chr18:51,464,733...83,218,561 JBrowse link
liver nonremodeling tumorous lesion volume to total liver volume ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar13 Hepatocarcinoma resistance QTL 13 IDA RGD PMID:15185337 RGD:737884 NCBI chr 4:1...32,584,199 JBrowse link
Q Hcas6 Hepatocarcinoma susceptibility QTL 6 IDA RGD PMID:15185337 RGD:737884 NCBI chr14:39,057,237...83,368,335 JBrowse link
Q Hcas7 Hepatocarcinoma susceptibility QTL 7 IDA RGD PMID:15185337 RGD:737884 NCBI chr15:2,266,368...46,921,453 JBrowse link
liver remodeling tumorous lesion number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Lnnr3 Liver neoplastic nodule remodeling QTL 3 IDA RGD PMID:15185337 RGD:737884 NCBI chr 2:1...41,244,106 JBrowse link
Q Lnnr4 Liver neoplastic nodule remodeling QTL 4 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:1...42,356,786 JBrowse link
Q Lnnr5 Liver neoplastic nodule remodeling QTL 5 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:59,874,408...85,581,182 JBrowse link
Q Lnnr6 Liver neoplastic nodule remodeling QTL 6 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:74,862,117...85,581,182 JBrowse link
liver remodeling tumorous lesion number to liver total tumorous lesion number ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Lnnr1 Liver neoplastic nodule remodeling QTL 1 IDA RGD PMID:12672032 RGD:629574 NCBI chr 7:34,293,282...79,293,282 JBrowse link
Q Lnnr2 Liver neoplastic nodule remodeling QTL 2 IDA RGD PMID:12672032 RGD:629574 NCBI chr 1:233,948,574...260,522,016 JBrowse link
liver total copper weight term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcuc2 Hepatic copper content QTL 2 IDA RGD PMID:11741328 RGD:619607 NCBI chr16:1...39,533,949 JBrowse link
liver tumorous lesion area to total liver area ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar7 Hepatocarcinoma resistance QTL 7 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:70,808,386...115,808,386 JBrowse link
Q Hcar8 Hepatocarcinoma resistance QTL 8 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:123,143,783...168,143,783 JBrowse link
liver tumorous lesion number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar10 Hepatocarcinoma resistance QTL 10 IDA RGD PMID:12154055 RGD:629566 NCBI chr 8:40,713,066...82,925,667 JBrowse link
Q Hcar11 Hepatocarcinoma resistance QTL 11 IDA RGD PMID:12154055 RGD:629566 NCBI chr 6:82,523,650...110,548,006 JBrowse link
Q Hcar15 Hepatocarcinoma resistance QTL 15 IDA RGD PMID:15771619 RGD:1358145 NCBI chr 1:153,136,852...260,522,016 JBrowse link
Q Hcar5 Hepatocarcinoma resistance QTL 5 IDA RGD PMID:10850431 RGD:619609 NCBI chr 1:214,537,555...226,660,468 JBrowse link
Q Hcar7 Hepatocarcinoma resistance QTL 7 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:70,808,386...115,808,386 JBrowse link
Q Hcas2 Hepatocarcinoma susceptibility QTL 2 IDA RGD PMID:10493520 RGD:619598 NCBI chr 1:5,925,874...115,540,829 JBrowse link
Q Hcas5 Hepatocarcinoma susceptibility QTL 5 IDA RGD PMID:15185337 RGD:737884 NCBI chr 1:176,426,412...257,976,495 JBrowse link
Q Hcas8 Hepatocarcinoma susceptibility QTL 8 IDA RGD PMID:17079458 RGD:1599590 NCBI chr16:1...22,477,621 JBrowse link
liver tumorous lesion number to liver area ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar4 Hepatocarcinoma resistance QTL 4 IDA RGD PMID:10850431 RGD:619609 NCBI chr 1:193,422,268...214,537,671 JBrowse link
liver tumorous lesion volume to total liver volume ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcas1 Hepatocarcinoma susceptibility QTL 1 IDA RGD PMID:10493520 RGD:619598 NCBI chr 7:91,412,594...129,807,172 JBrowse link
Q Hcas3 Hepatocarcinoma susceptibility QTL 3 IDA RGD PMID:12154055 RGD:629566 NCBI chr 1:144,267,353...222,987,745 JBrowse link
liver weight term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Livw4 Liver weight QTL 4 IDA RGD PMID:25296178 RGD:10402111 NCBI chr 7:70,840,118...72,474,897 JBrowse link
liver weight to body weight ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Livw1 Liver weight QTL 1 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 1:155,422,851...172,949,803 JBrowse link
Q Livw2 Liver weight QTL 2 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 5:99,016,066...119,085,810 JBrowse link
Q Livw3 Liver weight QTL 3 IDA RGD PMID:19526527 RGD:2316974 NCBI chr 8:4,705,810...49,705,810 JBrowse link
volume of individual liver tumorous lesion term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar1 Hepatocarcinoma resistance QTL 1 IDA RGD PMID:10493520 RGD:619598 NCBI chr10:6,154,182...15,990,232 JBrowse link
Q Hcar12 Hepatocarcinoma resistance QTL 12 IDA RGD PMID:12154055 RGD:629566 NCBI chr 3:29,463,235...118,376,539 JBrowse link
Q Hcar2 Hepatocarcinoma resistance QTL 2 IDA RGD PMID:10493520 RGD:619598 NCBI chr 4:78,878,504...123,878,504 JBrowse link
Q Hcar3 Hepatocarcinoma resistance QTL 3 IDA RGD PMID:10493520 RGD:619598 NCBI chr 8:54,237,644...99,103,503 JBrowse link
Q Hcar9 Hepatocarcinoma resistance QTL 9 IDA RGD PMID:12154055 RGD:629566 NCBI chr 4:109,866,907...167,139,601 JBrowse link
Q Hcas4 Hepatocarcinoma susceptibility QTL 4 IDA RGD PMID:12154055 RGD:629566 NCBI chr16:4,227,609...46,975,965 JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      liver measurement 39
        liver lesion measurement + 29
        liver lipid measurement + 2
        liver mineral measurement + 4
        liver morphological measurement + 10
        liver physiological measurement + 0
        liver protein/peptide measurement + 0
paths to the root